These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 26022528)

  • 41. Cost-effectiveness of cervical cancer prevention in Central and Eastern Europe and Central Asia.
    Berkhof J; Bogaards JA; Demirel E; Diaz M; Sharma M; Kim JJ
    Vaccine; 2013 Dec; 31 Suppl 7():H71-9. PubMed ID: 24332299
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Knowledge and intention to participate in cervical cancer screening after the human papillomavirus vaccine.
    Anhang Price R; Koshiol J; Kobrin S; Tiro JA
    Vaccine; 2011 Jun; 29(25):4238-43. PubMed ID: 21473953
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A qualitative analysis of South African women's knowledge, attitudes, and beliefs about HPV and cervical cancer prevention, vaccine awareness and acceptance, and maternal-child communication about sexual health.
    Francis SA; Battle-Fisher M; Liverpool J; Hipple L; Mosavel M; Soogun S; Mofammere N
    Vaccine; 2011 Nov; 29(47):8760-5. PubMed ID: 21855591
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Chinese medical students' knowledge, attitude and practice towards human papillomavirus vaccination and their intention to recommend the vaccine.
    Liu A; Ho FK; Chan LK; Ng JY; Li SL; Chan GC; Leung TF; Ip P
    J Paediatr Child Health; 2018 Mar; 54(3):302-310. PubMed ID: 28876498
    [TBL] [Abstract][Full Text] [Related]  

  • 45. HPV vaccine: A comparison of attitudes and behavioral perspectives between Latino and non-Latino women.
    Watts LA; Joseph N; Wallace M; Rauh-Hain JA; Muzikansky A; Growdon WB; del Carmen MG
    Gynecol Oncol; 2009 Mar; 112(3):577-82. PubMed ID: 19150120
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Barriers to human papillomavirus vaccine acceptability in Israel.
    Fisher WA; Laniado H; Shoval H; Hakim M; Bornstein J
    Vaccine; 2013 Nov; 31 Suppl 8():I53-7. PubMed ID: 24229720
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of Human Papillomavirus vaccination of daughters on the cervical screening uptake of their non-vaccinated mothers.
    Spencer AM; Roberts SA; Verma A; Patnick J; Elton P; Brabin L
    Eur J Public Health; 2015 Dec; 25(6):1097-100. PubMed ID: 26254459
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A qualitative study on HPV vaccination from a nursing perspective in Hong Kong.
    Chan CY; Lam CH; Lam DY; Lee LY; Ng KK; Wong ML
    Asian Pac J Cancer Prev; 2011; 12(10):2539-45. PubMed ID: 22320952
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of HPV vaccination and cervical cancer screening in England by ethnicity: a modelling study.
    Johnson HC; Lafferty EI; Eggo RM; Louie K; Soldan K; Waller J; Edmunds WJ
    Lancet Public Health; 2018 Jan; 3(1):e44-e51. PubMed ID: 29307388
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of numerical information on intention to participate in cervical screening among women offered HPV vaccination: a randomised study.
    Hestbech MS; Gyrd-Hansen D; Kragstrup J; Siersma V; Brodersen J
    Scand J Prim Health Care; 2016 Dec; 34(4):401-419. PubMed ID: 27845597
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Risk factors for cervical abnormalities among Hong Kong Chinese women: a large-scale community-based cervical screening program.
    Wong HY; Loke AY; Chan NH
    J Womens Health (Larchmt); 2011 Jan; 20(1):53-9. PubMed ID: 21091197
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Barriers and facilitators to human papillomavirus vaccination among Chinese adolescent girls in Hong Kong: a qualitative-quantitative study.
    Kwan TT; Chan KK; Yip AM; Tam KF; Cheung AN; Young PM; Lee PW; Ngan HY
    Sex Transm Infect; 2008 Jun; 84(3):227-32. PubMed ID: 18256106
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Adolescents' intention and self-efficacy to follow Pap testing recommendations after receiving the HPV vaccine.
    Higgins LM; Dirksing KN; Ding L; Morrow CD; Widdice LA; Kahn JA
    Hum Vaccin Immunother; 2016 Jun; 12(6):1498-503. PubMed ID: 26934107
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Primary and secondary prevention of cervical cancer among Italian AFAB transgender people.
    Lami A; Alvisi S; Siconolfi A; Seracchioli R; Meriggiola MC
    Curr Probl Cancer; 2024 Jun; 50():101103. PubMed ID: 38744064
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Social and cultural construction processes involved in HPV vaccine hesitancy among Chinese women: a qualitative study.
    Siu JY; Fung TKF; Leung LH
    Int J Equity Health; 2019 Sep; 18(1):147. PubMed ID: 31533722
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Examining the Cervical Screening Behaviour of Women Aged 50 or above and Its Predicting Factors: A Population-Based Survey.
    Chan CW; Choi KC; Wong RS; Chow KM; So WK; Leung DY; Lam WW; Goggins W
    Int J Environ Res Public Health; 2016 Dec; 13(12):. PubMed ID: 27918456
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The potential impact of a prophylactic vaccine for human papillomavirus on the current cervical screening programme in Hong Kong.
    Koljonen PA
    Hong Kong Med J; 2007 Aug; 13(4):304-10. PubMed ID: 17664535
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Knowledge, attitudes and practices of cervical cancer prevention among Zambian women and men.
    Nyambe A; Kampen JK; Baboo SK; Van Hal G
    BMC Public Health; 2019 May; 19(1):508. PubMed ID: 31054569
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hong Kong Chinese women's lay beliefs about cervical cancer causation and prevention.
    Wang LD; Lam WW; Wu J; Fielding R
    Asian Pac J Cancer Prev; 2014; 15(18):7679-86. PubMed ID: 25292046
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A transversal cross-sectional study of factors related to HPV vaccination status and cancer screening participation among French women aged 25-40.
    Serman F; Lisembard G; Sahraoui M; Berkhout C; Rochoy M; Haro A; Calafiore M
    BMC Cancer; 2024 Jul; 24(1):807. PubMed ID: 38971725
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.